Clinical Trials Directory

Trials / Completed

CompletedNCT06256159

Validity and Reliability of the 12-item Multiple Sclerosis Walking Scale (12-WS) in Subjects With Spinal Cord Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Established gait assessments for subjects with spinal cord injury (SCI) (6MWT, 10MWT, TUG, SCIM III and WISCI II) are widely used in the clinical and research setting. So far, no valid measurement exists that assesses the patients' perspective of walking ability in SCI. As there is the 12-item Multiple Sclerosis Walking Scale (12-WS) to assess the patients' perspective on gait ability in patients with multiple sclerosis, it is hypothesized that the 12-WS would also be a valid instrument for subjects with incomplete SCI. The main goal of this study is to collect data from clinical gait assessments in subjects with spinal lesions and to demonstrate that the 12-WS is a valid and reliable patient-reported outcome measurement for individuals with incomplete spinal cord injury.

Conditions

Interventions

TypeNameDescription
OTHER12 MSWS questionnaireThe subject has to perform different gait assessments and fill out the 12-item multiple sclerosis walking scale questionnaire in one visit. Maximum 8 weekes after the first visit the subject has to fill out the same questionnaire again.

Timeline

Start date
2024-03-22
Primary completion
2025-03-05
Completion
2025-03-05
First posted
2024-02-13
Last updated
2025-05-29

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06256159. Inclusion in this directory is not an endorsement.